Page last updated: 2024-08-26

Koenimbine and Breast Neoplasms

Koenimbine has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arun, A; Chourasia, MK; Karade, SS; Konwar, R; Patel, OPS; Saini, D; Singh, PK; Yadav, PP1
Ahmadipour, F; Arya, A; Fani, S; Firoozi, M; Kamalidehghan, B; Keong, YS; Looi, CY; Mohan, S; Noordin, MI; Paydar, M; Siyamak, EN; Sukari, MA; Yong, CL1

Other Studies

2 other study(ies) available for Koenimbine and Breast Neoplasms

ArticleYear
Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells.
    European journal of medicinal chemistry, 2019, Apr-01, Volume: 167

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carbazoles; Caspases; Cell Line, Tumor; Down-Regulation; Humans; Inhibitory Concentration 50; PC-3 Cells; Polymerization; Proto-Oncogene Proteins c-akt; Pyrans; Rats; TOR Serine-Threonine Kinases; Tubulin

2019
Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Biomarkers, Tumor; Breast Neoplasms; Carbazoles; CD24 Antigen; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; MCF-7 Cells; Murraya; Neoplastic Stem Cells; Structure-Activity Relationship; Tumor Cells, Cultured

2015